We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Omega Bio-Tek

Omega Bio-tek, Inc. offers high-quality, easy-to-use, and economical kits for all nucleic acid purification needs wit... read more Featured Products: More products

Download Mobile App





Omega Bio-tek Launches New Viral RNA Extraction Kit for COVID-19 Testing

By LabMedica International staff writers
Posted on 09 Jun 2020
Omega Bio-tek, Inc. More...
(Norcross, GA, USA) has launched the Mag-Bind Viral RNA Xpress Kit for the rapid and reliable isolation of Viral RNA from nasopharyngeal (NP) swab specimens that are dry or in viral transport media (VTM).

The new kit aims to combat the shortage of RNA purification kits, which is used in the first steps of COVID-19 testing. The new magnetic bead-based extraction kit is adaptable to most liquid handling platforms for scalable, high-throughput purification. Protocols are available for the Hamilton Microlab STAR, Hamilton Microlab MagEx STARlet, Hamilton Microlab NIMBUS, Thermo KingFisher, Qiagen BioSprint, Applied Biosystems MagMax 96, and the Tecan DreamPrep NAP.

The Mag-Bind Viral RNA Xpress Kit allows scientists to increase their purification throughput by reducing the number of reagents and protocol steps while allowing for efficient recovery of viral nucleic acids with minimal inhibitor carryover. Viral RNA purified using the Mag-Bind Viral RNA Xpress Kit is suitable for common downstream applications such as RT-qPCR.

"With the new Mag-Bind Viral RNA Xpress Kit, we are able to deliver a robust and reliable extraction product and triple our production capacity to produce up to six million tests per month," said Travis Butts, Vice President of Omega Bio-tek. "We are proud that we can assist scientists, researchers, and healthcare workers around the world in accelerating the screening and detection of the novel coronavirus, COVID-19, disease."



Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Drug Testing Assays
Atellica DT 250 Analyzer
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.